BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250827
DTEND;VALUE=DATE:20250830
DTSTAMP:20260515T065532
CREATED:20250513T120710Z
LAST-MODIFIED:20250513T120710Z
UID:41063-1756252800-1756511999@www.pharmajournalist.com
SUMMARY:5th Oligonucleotides for CNS Summit
DESCRIPTION:In a year where neurology has overtaken cancer as the number one indication prioritized by oligonucleotide drug developers\, now is the time to stay at forefront of ASO and siRNA innovation. Returning to Boston\, this August\, the 5th Oligonucleotides for CNS Summit unites 100+ biopharma leaders across RNA biology\, oligonucleotide chemistry\, DMPK\, pharmacology\, and platform technology\, to discover the latest advancements in brain delivery\, chemistry\, nonclinical safety and more! \nJoin your peers Alnylam Pharmaceuticals\, Denali Therapeutics\, Genentech\, FDA\, Novo Nordisk\, Regeneron\, Servier\, Stoke Therapeutics\, Ultragenyx Pharmaceutical and more\, to overcome key challenges\, build cross-modality relations\, unpack the latest clinical data and redefine the landscape of oligonucleotide research. \nWhat to Expect: \n\nBenchmark your chemistry and biology innovations with dual-tracked workshops developed for medicinal chemists and neurobiologists\nHear from 10+ new speakers\, including insights from the FDA and companies breaking ground across neuromuscular\, neurodegenerative\, neurodevelopmental and ultra-rare indications\nExplore the next wave of delivery tech\, from TfR1 and AOCs to computational CNS PK/PD modeling and novel RNA editing approaches\n\nCapitalize on the recent ‘oligonucleotide boom\,’ by attending this meeting! \nTo know more visit: https://ter.li/uw2usc
URL:http://www.pharmajournalist.com/event/5th-oligonucleotides-for-cns-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR